Advertisement
Screener

Pelthos Therapeutics Inc. (PTHS) Auditor

Pelthos Therapeutics Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-19: Fiscal year end 2025-12-31; Auditor CBIZ CPAs P.C.; PCAOB firm ID 199; Location Hartford, Connecticut.
  • 2025-03-27: Fiscal year end 2024-12-31; Auditor Marcum LLP; PCAOB firm ID 688; Location Hartford, Connecticut.
  • 2024-04-16: Fiscal year end 2023-12-31; Auditor Marcum LLP; PCAOB firm ID 688; Location Houston, Texas.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-192025-12-31CBIZ CPAs P.C.199Hartford, ConnecticutNo
2025-03-272024-12-31Marcum LLP688Hartford, Connecticut
2024-04-162023-12-31Marcum LLP688Houston, Texas

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37